Faculty Information - Yoshiyuki Miyaji

Current specialization

Journal Articles

Presentations

Professional Organizations

（Last updated : 2025-05-27 12:53:48）

Yoshiyuki Miyaji
Department Kawasaki Medical School Kawasaki Medical School, Department of Urology,

Position Professor with Special Assignment

■ Current specialization

Urology

■ Journal Articles

1.	2025/04/30	A case of advanced renal cell carcinoma with concomitant development of multiple endocrine neoplasia type 1 that affected treatment progress with immunotherapy
2.	2025/02/02	Real-world clinical usage and efficacy of apalutamide in men with nonmetastatic castration-resistant prostate cancer: a multi-institutional study in the CsJUC
3.	2024/05/20	Effect of Antacids on the Survival of Patients With Metastatic Urothelial Carcinoma Treated With Pembrolizumab
4.	2024/03	Long-term outcomes of salvage transurethral high-dose-rate brachytherapy combined with external beam radiation therapy for anastomotic recurrence of prostate cancer after radical prostatectomy: A retrospective analysis.
5.	2024/01	Rectal ulcer associated with lenvatinib 15 years after definitive radiotherapy for prostate cancer: A case report.
6.	2023/12/20	Prognostic impact of radiological tumor burden in patients with metastatic urothelial carcinoma treated with pembrolizumab
7.	2023/07/03	Spinal Instability as a Prognostic Factor in Patients With Spinal Metastasis of Castration-resistant Prostate Cancer.
8.	2022/03/30	Feasibility of magnetic resonance imaging-ultrasound guided high-dose-rate brachytherapy for localized prostate cancer: Preliminary results from a prospective study.
9.	2021/08/25	Quantitative diffusion-weighted imaging and dynamic contrast-enhanced MR imaging for assessment of tumor aggressiveness in prostate cancer at 3T
10.	2021/06/25	Case Report: Malignant Pheochromocytoma Without Hypertension Accompanied by Increment of Serum VEGF Level and Catecholamine Cardiomyopathy
11.	2021/05	VI-RADS: Multiinstitutional Multireader Diagnostic Accuracy and Interobserver Agreement Study
12.	2021/01	Comparison of Biparametric and Multiparametric MRI for Clinically Significant Prostate Cancer Detection With PI-RADS Version 2.1.
13.	2019/12	Comparison of PI-RADS version 2 and PI-RADS version 2.1 for the detection of transition zone prostate cancer
14.	2018/01	Chronic reactive arthritis associated with prostatitis caused by Neisseria meningitidis.
15.	2004/07	Effects of gonadotropin-releasing hormone agonists on bone metabolism markers and bone mineral density in patients with prostate cancer.
16.	2022/07/01	Mixed epithelial and stromal tumor of the kidney composed mainly of solid components: A case report
17.	2018	Male squirting: Analysis of one case using color Doppler ultrasonography
18.	2016/11	Tadalafil for male lower urinary tract symptoms improves endothelial function
19.	2015/06	Practical application of color Doppler ultrasonography in patients with ejaculatory dysfunction
20.	2013/06	Vasohibin-1 is a new predictor of disease-free survival in operated patients with renal cell carcinoma
21.	2014/05	High b value (2,000 s/mm2) diffusion-weighted magnetic resonance imaging in prostate cancer at 3 Tesla : comparison with 1,000 s/mm2 for tumor conspicuity and discrimination of aggressiveness
22.	2007/12	The experience of using dual lumen ureteral access sheath (AquaGuide TM)in ureteropyeloscopy
23.	2016/09	Value of Preoperative 3T Multiparametric MRI for Surgical Margin Status in Patients With Prostate Cancer
24.	2012/03	Salvage high-dose-rate brachytherapy for local prostate cancer recurrence after radiotherapy - preliminary results.
25.	2011/03	Effects of three types of alpha-1 adrenoceptor blocker on lower urinary tract symptoms and sexual function in males with benign prostatic hyperplasia
26.	2009/10	Does transection of the spermatic cord lower the incidence of inguinal hernia after radical retropubic prostatectomy?
27.	2019/02	Multidimensional analysis of clinicopathological characteristics of false-negative clinically significant prostate cancers on multiparametric MRI of the prostate in Japanese men.
28.	2008/10	Ejaculatory dysfunction caused by new A1-blocker:analysis of human ejaculatory phenomenon using color doppler ultrasonigraphy
29.	2011/06	Retroperitoneoscopic Nephrectomy for Treatment of a Case of Left Single Ectopic Ureter Accompanied by Dysplastic Kidney
30.	2007	Routinr Transurethral Biopsy of the Bladder Is Not Necessary to Evaluate the Response to Bacillus Calmette-Guerrin Therapy
31.	2019/10/15	Early Experience with MRI-ultrasound Fusion-guided Prostate Biopsy in Japanese Men with Elevated PSA Levels
32.	2017/03	Incremental value of high b value diffusion-weighted magnetic resonance imaging at 3-T for prediction of extracapsular extension in patients with prostate cancer: preliminary experience.
33.	2009/04	Naftopidil and Propiverin Hydrochrolide for treatment of male lower urinary tract symptoms suggestive of benign prostatic hyperplasia and concomitant overactive bladder: A prospective randomized controlled study
34.	2012/01	Comparison of two different alpha1-adrenoceptor antagonists, tamsulosin hydrochloride and silodosin, in the treatment of male lower urinary tract symptoms suggestive of benign prostatic hyperplasia: A prospective randomized crossover study.
35.	2011/08	MRI appearance of prostatic stromal sarcoma in a young adult
36.	2009/04	The effect of purified newly developed Botulinum neurotoxin type A in rat and human prostate
37.	2019/03	Intra-abdominal desmoid tumor mimicking local recurrence of renal cell carcinoma after laparoscopic partial nephrectomy.
38.	2004/05	Comparative study of ureteral stripping versus open ureterectomy for nephroureterectomy in patients with transitional carcinoma of the renal pelvis
39.	2013/02	Long-term safety and efficacy of two different antimuscarinics, imidafenacin and solifenacin, for treatment of overactive bladder: a prospective randomized controlled study.
40.	2009/10	The Effects of 3 Types of Alpha1-Adrenoceptor Blockers on Lower Urinary Tract Symptoms and Sexual Functions in Men with Benign Prostatic Hyperplasia
41.	2008/02	Optimal approach for prostate cancer detection as initial biopsy: prospective randomized study comparing transperineal versus transrectal systematic 12-core biopsy.
42.	2012/04	Preoperative positive urine cytology is a risk factor for subsequent development of bladder cancer after nephroureterectomy in patients with upper urinary tract urothelial carcinoma
43.	2020	Outcomes of robot-assisted partial nephrectomy in the treatment of renal cell carcinoma at Kawasaki Medical School Hostiptal
44.	2022/01/19	Anti-inflammatory effect of tadalafil, a phosphodiesterase 5 (PDE5) inhibitor, in autoimmune prostatitis
45.	2009/04	Is primary hormone therapy efficient for clinically localized prostate cancer in Japanese men?
46.	2017/08	Long-term compliance and treatment failure of alpha1-blocker for patients with benign prostatic hyperplasia
47.	2024	Short repetition time diffusion-weighted imaging improves visualization of prostate cancer
Display 5 items
Display all(47)

■ Presentations

1.	2009/11/03	Does transection of the spermatic cord lower the incidence of inguinal hernia after radical retropubic prostatectomy? （Poster notice，General）
2.	2025/01/11	The utility of preoperative and intraoperative simulations using case models based on three-dimensional medical illustration techniques derived from biological digital imaging and communications in medicine data. （Speech，General）
3.	2024/09/05	Magnetic resonance imaging-ultrasound fusion-guided ultrafocal high-dose-rate brachytherapy for primary localized prostate cancer （Speech，General）
4.	2024/04/27	Catheterization with Laparoscopic CAPD using the Peritoneal Wall Anchor Technique at Kawasaki Medical School Hospital （Poster notice，General）
5.	2024/04/12	Long-Term Results of Salvage High-Dose-Rate Brachytherapy for Local Recurrence of Prostate Cancer after Definitive Radiotherapy. （Speech，General）
6.	2023/10/25	A prospective study of MRI-ultrasound fusion-guided focal high-dose-rate brachytherapy for primary localized prostate cancer （Poster notice，General）
7.	2023/04/20	川崎医科大学附属病院における転移性腎癌に対する免疫複合療法の治療成績 Outcomes of Combined Immunotherapy for Metastatic Renal Cancer at Kawasaki Medical School Hospital （Poster notice，General）
8.	2023/04/20	未治療限局性前立腺癌を対象としたMRI-US 画像融合下限局高線量率組織内照射療法(MRI-US fusion-guided ultrafocal high-dose-rate brachytherapy) の初期経験(第2 報) A prospective study of MRI-ultrasound fusion-guided ultrafocal high-dose-rate brachytherapy (HDR-BT) for primary localized prostate cancer （Poster notice，General）
9.	2023/04/16	ホルモン療法を併用しない高リスク前立腺癌に対する外照射併用高線量率組織内照射の長期治療成績の検討（Speech，General）
10.	2022/04/16	A preliminary report of a prospective study of MRI-ultrasound fusion-guided ultrafocal high-dose rate brachytherapy for localized prostate cancer （Speech，General）
11.	2020/07	90 Anti-inflammatory effect of IDO1 inhibition for acute inflammation in the prostate （Poster notice，General）
12.	2020/07	New pathological subtype of renal cell carcinoma in patients on long-term dialysis: acquired cystic disease-associated renal cell carcinoma （General）
13.	2020/07	Pathological analysis focused on inflammatory changes in bladder dysfunction following partial bladder outlet obstruction （Poster notice，General）
14.	2019/12/01	Clinical Implementation of MRI-ultrasound Fusion-guided Prostate Biopsy in the Management of Prostate Cancer: What Radiologists Should Know （General）
15.	2019/11/09	Preventive effect of tadalafil for chronic inflammation in the prostate （Speech，General）
16.	2019/10/19	Renal Cell Carcinoma in Japanese Patients with End-Stage Renal Disease （Poster notice，General）
17.	2019/10/19	Validation of the Prostate Imaging and Reporting Data System Version 2(PI-RADS v2) for the detection of prostate cancer in Japanese men with elevated PSA Level. （Poster notice，General）
18.	2019/05/10	Comparison of Stretched-Exponential, IVIM and Monoexponential Diffusion-Weighted Imaging Mathematical Models for Assessment of Tumor Aggressiveness in Prostate Cancer at 3T （Speech，General）
19.	2019/04/11	The application of color Doppler ultrasonography in patients with ejaculation dysfunction and a male volunteer with the squirting phenomenon after ejaculation: an update （Poster notice，General）
20.	2019/03/17	Changes in circulating blood volume measured by pulse dye-densitometry during preoperative management with an α-blocker in patients with pheochromocytoma （Poster notice，General）
21.	2019/03/17	Therapeutic effect of tadalafil in the chronic prostatitis （Poster notice，General）
22.	2018/09/23	Laparoscopic adrenal-sparing surgery in pheochromocytoma associated with multiple endocrine neoplasia type 2A （Speech，General）
23.	2018/09/07	高PSA血症例に対する前立腺MRI-超音波融合画像ガイド下生検の初期経験（Speech，General）
24.	2018/05/18	Risk of secondary bladder cancer after high dose rate brachytherapy for prostate cancer （Speech，General）
25.	2018/04/19	The role of indoleamine 2,3-dioxygenase (IDO) in prostatitis （Speech，General）
26.	2018/04/18	The risk of urothelial carcinoma of the bladder in prostate cancer patients treated with high-dose-rate brachytherapy: a case-control study （Poster notice，General）
27.	2017/10/19	Prospective study of a switching GnRH agonist therapy in castration resistant prostate cancer in Japanese patients （Poster notice，General）
28.	2017/05/12	Therapeutic effect of indoleamine 2,3-dioxygenase inhibitor in epididymitis （Speech，General）
29.	2017/05/12	Therapeutic effect of RIPK1 inhibitor in testicular ischemia-reperfusion （Poster notice，General）
30.	2017/03/24	Therapeutic effect of indoleamine 2,3-dioxygenase inhibitor in epididymitis （Poster notice，General）
31.	2017/03/24	Therapeutic effect of RIPK1 inhibitor in testicular ischemia-reperfusion （Speech，General）
32.	2017/01/14	Effects of microscopic subinguinal varicocelectomy on semen analysis findings and fertility of infertile male patients with varicocele （Poster notice，General）
33.	2016/11/11	Endoscopic removal of Memotherm^R using holmium YAG laser:A report of 3 cases （Poster notice，General）
34.	2016/11/11	Initial experience with the EMARO pneumatic laparoscopic holder robot in laparoscopic urological surgery
35.	2016/11/11	Therapeutic results and complications of ureteroscopic lithotripsy （Poster notice，General）
36.	2016/05/07	Tadalafil for male LUTS improves endothelial function （Speech，General）
37.	2016/05/07	The role of indoleamine 2,3-dioxygenase in epididymitis （Speech，General）
38.	2016/04/02	Effects of microscopic subinguinal varicocelectomy on semen analysis findings and fertility of infertile male patients with varicocele （Speech，General）
39.	2016/04/01	Pilot study of penile brachial index for Erectile Dysfunction （Speech，General）
40.	2016/03/12	The role of indoleamine 2,3-dioxygenase in epididymitis （Speech，General）
41.	2015/02	Evaluation of vascular endothelial function for patients with Erectile Dysfunction （Poster notice，General）
42.	2015/02	Maintenance of oral administration of anticholinergic drugs for overactive bladder （Poster notice，General）
43.	2014/10/23	Change of sexual functions in patients with benign prostatic hyperplasia after holmium laser enucleation of the prostate (HoLEP). （Speech）
44.	2014/09/04	Unilateral adrenalectomy followed by contralateral laparoscopic partial adrenalectomy for men 2a: A report of two cases （Speech，General）
45.	2013/11/07	The relationships between salivary testosterone, serum sex hormones and lower urinary tract symptoms, sexual function in patients with benign prostate hyperplasia. （Speech，General）
46.	2013/11/07	Use of PDE5 inhibitors in elderly at Kawasaki medical school. （Speech，General）
47.	2013/10/24	A peritoneal wall anchor technique using a new device for laparoscopy-assisted catheter placement in peritoneal dialysis （Speech，General）
48.	2013/09/11	Spectrum of renal cell carcinoma histological subtypes arising end-stage renal disease. （Poster notice，General）
49.	2013/09/09	Change of Urinary, Sexual, and Bowel Function after Holmium Laser Enucleation of the Prostate (HoLEP) for Benign Prostatic Hyperplasia. （Poster notice，General）
50.	2013/09/09	The Relationships between Salivary Testosterone, Serum Sex Hormones and Lower Urinary Tract Symptoms, Sexual Function in Patients with Benign Prostate Hyperplasia. （Poster notice，General）
51.	2013/05/07	Correlation of urinary oxidant stress marker level with the response of antimuscarinic therapy in patients with female overactive bladder （Speech，General）
52.	2013/03/16	Vasohibin-1 is a novel independent predictor of disease-free survival in curatively operated renal cell carcinoma patients （Poster notice，General）
53.	2013/02/14	Change of sexual functions in patients with benign prostatic hyperplasia after holmium laser enucleation of the prostate (HoLEP) （Poster notice，General）
54.	2013/02/14	Comparison of transperineal and transrectal 12-core initial prostate biopsy with PSA levels between 4.0 and 20.0 ng/ml （Speech，General）
55.	2013/02/14	Correlation with urothelium and primary symptoms in interstitial cystitis: investigation of scanning electron microscopy （Poster notice，General）
56.	2013/02/14	Investigation of histological feature and bladder function in rat insterstitial cystitis model （Poster notice，General）
57.	2012/10/01	Long-Term Compliance and Treatment Failure of alpha1-Blocker for Patients with Male Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia. （Poster notice，General）
58.	2012/09/07	Incidental Prostate Cancer in Holmium Laser Enucleation of the Prostate (HoLEP) （Poster notice，General）
59.	2012/09/05	Prognostic factors in subsequent development of bladder cancer after the surgical management of primary upper urinary tract urothelial carcinoma （Poster notice，General）
60.	2012/08/04	Analysis of human ejaculation using color Doppler ultrasonography （Speech，Panelist at Symposium/Workshop (Other)）
61.	2012/08/04	Evaluation of patients with symptoms of male andropause （Poster notice，General）
62.	2012/05/22	Improvement of sexual function in patients with benign prostatic hyperplasia treated by holmium laser enucleation of the prostate (HoLEP) （Speech，General）
63.	2012/05/21	Clinical efficacy of a new botulinum toxin type A free of complexing proteins in the treatment of refractory neurogenic and idiopathic detrusor overactivity （Poster notice，General）
64.	2012/05/21	Correlation with urinary epithelium and primary symptoms in interstitial cystitis: investigation of scanning electron microscopy （Speech，General）
65.	2012/04/23	Improvement of sexual function in patients with benign prostatic hyperplasia treated by holmium laser enucleation of the prostate (HoLEP) （Speech，General）
66.	2012/02/04	Use of Fuhrman grading system for Japanese patients with renal cell carcinoma （Poster notice，General）
67.	2011/10/29	Forty percent of patients with ureteral stones who visit the emergency room first are not followed by urologists. （Speech，General）
68.	2011/10/29	Health-Related Quality of Life in Patients with Localized Prostate Cancer Received High-Dose-Rate Brachytherapy: A Time-Course Analysis. （Speech）
69.	2011/10/29	Salvage high-dose-rate brachytherapy for local prostate cancer recurrence after initial treatment. （Speech，General）
70.	2011/10/19	Comparison of Two Different Antimuscarinics, Imidafenacin and Solifenacin for Treatment of Overactive Bladder: A Prospective Randomized Controlled Study （Poster notice，General）
71.	2011/10/19	Correlation of Urinary Nerve Growth Factor Level With the Response of Antimuscarinic Therapy in Patients With Overactive Bladder （Poster notice，General）
72.	2011/10/18	Correlation with Urinary Epithelium and Primary Symptoms in Interstitial Cystitis: Inbestigation of Scannin Electron Microscopy （Poster notice，General）
73.	2011/10/18	Risk Factor Analysis of Patients’Dissatisfaction After Holmium LaserEnucleation of the Prostate (HoLEP)for Benign Prostatic Hyperplasia （Poster notice，General）
74.	2011/10/17	Efficacy of Transperineal Versus Transrectal 12-Core Initial Prostate Biopsy with PSA Levels Between 4.0 and 20.0 ng/ml （Speech，General）
75.	2011/10/17	Prognostic Factors and Survival of Renal Cell Carcinoma in Japanese Patients （Poster notice，General）
76.	2011/10/17	Retroperitoneal Dedifferentiated Liposarcoma with Production of Granulocyte Colony-Stimulating Factor (G-CSF) Accompanied by Spontaneous Rupture: PET/CT Imaging of a G-CSF-Producting Tumor （Poster notice，General）
77.	2011/09/01	Comparison of two different antimuscarinics, Imidafenacine and solifenacin, for treatment of overactive bladder: A prospective randomized controlled study （Poster notice，General）
78.	2011/08/31	Correlation of urinary nerve growth factor level with the response of antimuscarinic therapy in patients with overactive bladder （Poster notice，General）
79.	2011/08/31	Correlation with urinary epithelium and primary symptoms in interstitial cystitis: investigation of scanning electron microscopy （Poster notice，General）
80.	2010/07/09	Function of Prostate in Ejaculation （Speech，Panelist at Symposium/Workshop (Other)）
81.	2009/11/01	The Effects of 3 Types of Alpha1-Adrenoceptor Blockers on Lower Urinary Tract Symptoms and Sexual Functions in Men with Benign Prostatic Hyperplasia
82.	2008/09/20	Clinical outcome in patients with locally and locally advanced prostate cancer treated with high-dose-rate brachytherapy. （Speech，General）
83.	2008/09/20	Optimal approach for prostate cancer detection as initial biopsy:A prospective randomized study comparing transperineal versus transrectal systematic 12-core biopsy. （Speech，General）
84.	2007/11/17	IRIDIUM-192 HIGH-DOSE-RATE BRACHYTHERAPY FOR T1c-T3bN0M0 PROSTATE CANCER （Speech）
85.	2007/09/02	IRIDIUM-192 HIGH-DOSE-RATE BRACHYTHERAPY FOR T1c-T3bN0M0 PROSTATE CANCER （Speech，General）
86.	2007/05/19	Correlation　of urinary nerve growth factor level with pathogenesis of overactive bladder （Poster notice）
87.	2007/05/19	Ejaculatory dysfunction caused by new A1-blocker: analysis of human ejaculatory phenomenon using color doppler ultrasonography （Speech）
88.	2006/09/15	The experience of using dual lumen ureteral access sheath (AquaGuideTM) in ureteropyeloscopy （General）
Display 5 items
Display all(88)

■ Professional Organizations

1.	2011/10～	American Urological Association
2.	2012/02～	Endurological Society